Anti-gastric cancer active immunity induced by FasL/B7-1 gene-modified tumor cells

doi:10.3748/wjg.v11.i21.3204

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3337)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-10) series.

Item

Count

PDF

341

HTML

2740

Figures (1-10)

256

Sum=3337

Jun 7, 2005 (publication date) through Feb 1, 2025

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Jun 7, 2005; 11(21): 3204-3211
Published online Jun 7, 2005. doi: 10.3748/wjg.v11.i21.3204

Full Size Figure Download Figure

Figure 7 Tumorigenicity of FB-11-transfected gastric cancer cells and tumor size in preventive and control groups. ●: FB-11 preventive group; ■: control group.

Citation: Zheng SY, Li DC, Zhang ZD, Zhao J, Ge JF. Anti-gastric cancer active immunity induced by FasL/B7-1 gene-modified tumor cells. World J Gastroenterol 2005; 11(21): 3204-3211
URL: https://www.wjgnet.com/1007-9327/full/v11/i21/3204.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i21.3204